Neuronetics is committed to providing you and your staff with resources to assist in the reimbursement process and gain patient access for treatment with NeuroStar TMS Therapy. Below are the reimbursement resources to assist you with submitting individual patient cases to the insurance companies for coverage.

Template Letters:

Prior Approval Template Letter To be used when requesting a prior approval before treatment begins.

Appeal Template Letter To be used when appealing the initial levels of a preauthorization request and/or a claims denial.

External Review Template Letter To be used when appealing the next level after the initial appeals of a preauthorization request and/or a claims denial with an organization outside the insurance company.

Supportive Documentation:

NeuroStar TMS Therapy® Executive Summary Overview of NeuroStar TMS Therapy and important clinical data.

TMS Therapy Bibliography List of key publications for TMS Therapy.

NeuroStar TMS Therapy FDA Clearance Letters Official letters provided by the FDA indicating FDA clearance for NeuroStar TMS Therapy.

AMA CPT I Code Approval Letter Official letter provided by the American Medical Association (AMA) designating CPT I codes for TMS Therapy.

All reimbursement information provided by Neuronetics is for general guidance only. It does not represent a statement, promise, or guarantee by Neuronetics concerning levels of reimbursement, payment, or charge, if any. Coverage and payment for NeuroStar TMS Therapy is based on various factors, including but not limited to, medical necessity, the patient’s specific benefits plan, and individual insurance company’s policies and guidelines. It is the responsibility of the physician and the patient to be knowledgeable of the applicable guidelines.

See frequently asked questions about medical coverage policies